154 related articles for article (PubMed ID: 35718064)
1. Evidence of brain-derived neurotrophic factor in ameliorating cancer-related cognitive impairment: A systematic review of human studies.
Ng DQ; Chan D; Agrawal P; Zhao W; Xu X; Acharya M; Chan A
Crit Rev Oncol Hematol; 2022 Aug; 176():103748. PubMed ID: 35718064
[TBL] [Abstract][Full Text] [Related]
2. Associations of plasma brain-derived neurotrophic factor (BDNF) and Val66Met polymorphism (rs6265) with long-term cancer-related cognitive impairment in survivors of breast cancer.
Yap NY; Tan NYT; Tan CJ; Loh KW; Ng RCH; Ho HK; Chan A
Breast Cancer Res Treat; 2020 Oct; 183(3):683-696. PubMed ID: 32696315
[TBL] [Abstract][Full Text] [Related]
3. Associations of brain-derived neurotrophic factor rs6265 polymorphism and cognitive function in breast cancer survivors from a cross-sectional study.
Goto T; Saligan LN; Li X; Xiang L; Kwiat C; Nguyen C; Crouch A; Von Ah D
Cancer Med; 2024 Jan; 13(2):e6975. PubMed ID: 38379321
[TBL] [Abstract][Full Text] [Related]
4. Brain-derived neurotrophic factor genetic polymorphism (rs6265) is protective against chemotherapy-associated cognitive impairment in patients with early-stage breast cancer.
Ng T; Teo SM; Yeo HL; Shwe M; Gan YX; Cheung YT; Foo KM; Cham MT; Lee JA; Tan YP; Fan G; Yong WS; Preetha M; Loh WJ; Koo SL; Jain A; Lee GE; Wong M; Dent R; Yap YS; Ng R; Khor CC; Ho HK; Chan A
Neuro Oncol; 2016 Feb; 18(2):244-51. PubMed ID: 26289590
[TBL] [Abstract][Full Text] [Related]
5. Cancer-related cognitive impairment: an update on state of the art, detection, and management strategies in cancer survivors.
Lange M; Joly F; Vardy J; Ahles T; Dubois M; Tron L; Winocur G; De Ruiter MB; Castel H
Ann Oncol; 2019 Dec; 30(12):1925-1940. PubMed ID: 31617564
[TBL] [Abstract][Full Text] [Related]
6. Replication and Meta-analysis of the Association between BDNF Val66Met Polymorphism and Cognitive Impairment in Patients Receiving Chemotherapy.
Tan CJ; Lim SWT; Toh YL; Ng T; Yeo A; Shwe M; Foo KM; Chu P; Jain A; Koo SL; Dent RA; Ng RCH; Yap YS; Lim EH; Loh KW; Chay WY; Lee GE; Tan TJY; Beh SY; Wong M; Chan JJ; Khor CC; Ho HK; Chan A
Mol Neurobiol; 2019 Jul; 56(7):4741-4750. PubMed ID: 30382534
[TBL] [Abstract][Full Text] [Related]
7. Brain-derived neurotrophic factor as a biomarker in cancer-related cognitive impairment among adolescent and young adult cancer patients.
Ng DQ; Cheng I; Wang C; Tan CJ; Toh YL; Koh YQ; Ke Y; Foo KM; Chan RJ; Ho HK; Chew L; Bin Harunal Rashid MF; Chan A
Sci Rep; 2023 Sep; 13(1):16298. PubMed ID: 37770565
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of plasma brain-derived neurotrophic factor levels and self-perceived cognitive impairment post-chemotherapy: a longitudinal study.
Ng T; Lee YY; Chae JW; Yeo AHL; Shwe M; Gan YX; Ng RCH; Chu PPY; Khor CC; Ho HK; Chan A
BMC Cancer; 2017 Dec; 17(1):867. PubMed ID: 29258453
[TBL] [Abstract][Full Text] [Related]
9. The Brain-Derived Neurotrophic Factor Functional Polymorphism and Hand Grip Strength Impact the Association between Brain-Derived Neurotrophic Factor Levels and Cognition in Older Adults in the United States.
Liu T; Li H; Conley YP; Primack BA; Wang J; Li C
Biol Res Nurs; 2022 Apr; 24(2):226-234. PubMed ID: 34974714
[TBL] [Abstract][Full Text] [Related]
10. Relationship between cytokines and brain-derived neurotrophic factor (BDNF) in trajectories of cancer-related cognitive impairment.
Yap NY; Toh YL; Tan CJ; Acharya MM; Chan A
Cytokine; 2021 Aug; 144():155556. PubMed ID: 33985854
[TBL] [Abstract][Full Text] [Related]
11. Brain derived neurotrophic factor in perioperative neurocognitive disorders: Current evidence and future directions.
Travica N; Aslam H; O'Neil A; Lane MM; Berk M; Gamage E; Walder K; Liu ZSJ; Segasby T; Marx W
Neurobiol Learn Mem; 2022 Sep; 193():107656. PubMed ID: 35792324
[TBL] [Abstract][Full Text] [Related]
12. Peripheral inflammatory and neurotrophic biomarkers of cognitive impairment in schizophrenia: a meta-analysis.
Bora E
Psychol Med; 2019 Sep; 49(12):1971-1979. PubMed ID: 31284882
[TBL] [Abstract][Full Text] [Related]
13. Associations between brain-derived neurotrophic factor and cognitive impairment in panic disorder.
Wang W; Liu Y; Luo S; Guo X; Luo X; Zhang Y
Brain Behav; 2020 Dec; 10(12):e01885. PubMed ID: 33047489
[TBL] [Abstract][Full Text] [Related]
14. The Influence of BDNF Val66Met Polymorphism on Cognition, Cerebrospinal Fluid, and Neuroimaging Markers in Non-Demented Elderly.
Xia H; Wang M; Li JQ; Tan CC; Cao XP; Tan L; Yu JT;
J Alzheimers Dis; 2019; 68(1):405-414. PubMed ID: 30775992
[TBL] [Abstract][Full Text] [Related]
15. Brain-derived neurotrophic factor in fibromyalgia: A systematic review and meta-analysis of its role as a potential biomarker.
Behnoush AH; Khalaji A; Khanmohammadi S; Alehossein P; Saeedian B; Shobeiri P; Teixeira AL; Rezaei N
PLoS One; 2023; 18(12):e0296103. PubMed ID: 38127937
[TBL] [Abstract][Full Text] [Related]
16. Impact of APOE and BDNF Val66Met Gene Polymorphisms on Cognitive Functions in Patients with Amnestic Mild Cognitive Impairment.
Cechova K; Andel R; Angelucci F; Chmatalova Z; Markova H; Laczó J; Vyhnalek M; Matoska V; Kaplan V; Nedelska Z; Ward DD; Hort J
J Alzheimers Dis; 2020; 73(1):247-257. PubMed ID: 31771052
[TBL] [Abstract][Full Text] [Related]
17. The impact of BDNF Val66Met polymorphism on cognition in Bipolar Disorder: A review: Special Section on "Translational and Neuroscience Studies in Affective Disorders" Section Editor, Maria Nobile MD, PhD. This Section of JAD focuses on the relevance of translational and neuroscience studies in providing a better understanding of the neural basis of affective disorders. The main aim is to briefly summaries relevant research findings in clinical neuroscience with particular regards to specific innovative topics in mood and anxiety disorders.
Mandolini GM; Lazzaretti M; Pigoni A; Delvecchio G; Soares JC; Brambilla P
J Affect Disord; 2019 Jan; 243():552-558. PubMed ID: 30078664
[TBL] [Abstract][Full Text] [Related]
18. Polymorphisms in the brain-derived neurotrophic factor gene influence memory and processing speed one month after brain injury.
McAllister TW; Tyler AL; Flashman LA; Rhodes CH; McDonald BC; Saykin AJ; Tosteson TD; Tsongalis GJ; Moore JH
J Neurotrauma; 2012 Apr; 29(6):1111-8. PubMed ID: 22188054
[TBL] [Abstract][Full Text] [Related]
19. Cognitive and magnetic resonance imaging brain morphometric correlates of brain-derived neurotrophic factor Val66Met gene polymorphism in patients with schizophrenia and healthy volunteers.
Ho BC; Milev P; O'Leary DS; Librant A; Andreasen NC; Wassink TH
Arch Gen Psychiatry; 2006 Jul; 63(7):731-40. PubMed ID: 16818862
[TBL] [Abstract][Full Text] [Related]
20. Genetic risk factors for cancer-related cognitive impairment: a systematic review.
Buskbjerg CDR; Amidi A; Demontis D; Nissen ER; Zachariae R
Acta Oncol; 2019 May; 58(5):537-547. PubMed ID: 30822178
[No Abstract] [Full Text] [Related]
[Next] [New Search]
